Shi Weibin, Vu To-Nhu, Annaswamy Thiru, Wu Hong, Moore Bryan, Hatchard Nicole, Mears Chad, Kunselman Allen R
Department of Physical Medicine and Rehabilitation, Penn State Health Milton S Hershey Medical Center / Penn State College of Medicine, Hershey, PA, USA.
Penn State Hershey Rehabilitation Hospital, Hummelstown, PA, USA.
Interv Pain Med. 2024 Feb 24;3(1):100390. doi: 10.1016/j.inpm.2024.100390. eCollection 2024 Mar.
Genicular nerve radiofrequency ablation (GNRFA) is a popular and effective procedure to treat arthritic knee pain. For refractory arthritic pain that fails conservative treatment, total knee arthroplasty (TKA) has been an excellent option. Unfortunately, 15-30% of people who undergo a TKA continue to experience pain and stiffness in the knee. The treatment options for post-TKA knee pain are limited. Pain providers have been trialing GNRFA on this pain condition. However, convincing evidence of its efficacy in treating post-TKA pain is still lacking.
This is a retrospective study of 73 patients who had undergone genicular nerve RFA, 46 (63.01%) with osteoarthritic pain, and 27 (36.99%) with post-TKA pain. We compared the outcomes (pain relief, function, and complications) between these two groups at 3 months and 6 months after RFA.
Before RFA, there was no significant difference in initial pain and functional level between these two groups. After RFA, the two groups had comparable pain relief at 3 months (p = 0.68) and 6 months (p = 0.53), and similar functionality at 3 months (p = 0.36) and 6 months (p = 0.65).The overall success rate (≥50% pain relief after RFA) was 80.82%, 95% CI: 70.34%-88.22% (osteoarthritic group 80.43%, 95% CI: 66.83%-89.35%, post-TKA 81.48%, 95% CI: 63.30%-91.82%, P = 0.91) at 3-month follow-up and 56.16%, 95% CI: 44.76%-66.95% (osteoarthritic group 56.52%, 95% CI: 42.25%-69.79%, post-TKA 55.56%, 95% CI: 37.31%-72.41%, P = 0.94) at 6-month follow-up.There were no reported complications in either group.
Genicular Nerve Radiofrequency Ablation (GNRFA) holds the potential to be equally effective for both post-TKA knee pain and osteoarthritic knee pain.
膝神经射频消融术(GNRFA)是一种治疗膝关节炎疼痛的常用且有效的方法。对于保守治疗无效的顽固性关节炎疼痛,全膝关节置换术(TKA)一直是一个很好的选择。不幸的是,15%至30%接受TKA的患者膝关节仍持续疼痛和僵硬。TKA术后膝关节疼痛的治疗选择有限。疼痛治疗医生一直在对这种疼痛情况试用GNRFA。然而,仍缺乏其治疗TKA术后疼痛疗效的确凿证据。
这是一项对73例行膝神经射频消融术患者的回顾性研究,其中46例(63.01%)患有骨关节炎疼痛,27例(36.99%)患有TKA术后疼痛。我们比较了两组在射频消融术后3个月和6个月时的结果(疼痛缓解、功能和并发症)。
在射频消融术前,两组的初始疼痛和功能水平无显著差异。射频消融术后,两组在3个月(p = 0.68)和6个月(p = 0.53)时疼痛缓解程度相当,在3个月(p = 0.36)和6个月(p = 0.65)时功能相似。总体成功率(射频消融术后疼痛缓解≥50%)在3个月随访时为80.82%,95%置信区间:70.34%-88.22%(骨关节炎组80.43%,95%置信区间:66.83%-89.35%,TKA术后81.48%,95%置信区间:63.30%-91.82%,P = 0.91),在6个月随访时为56.16%,95%置信区间:44.76%-66.95%(骨关节炎组56.52%,95%置信区间:42.25%-69.79%,TKA术后55.56%,95%置信区间:37.31%-72.41%,P = 0.94)。两组均未报告并发症。
膝神经射频消融术(GNRFA)对TKA术后膝关节疼痛和骨关节炎膝关节疼痛可能同样有效。